What distinguishes secondary hyperparathyroidism due to chronic kidney disease from tertiary hyperparathyroidism?

• A. Secondary is compensatory PTH elevation due to hypocalcemia or vitamin D deficiency; tertiary is autonomous PTH secretion after prolonged exposure.
• B. Secondary is autonomous PTH secretion; tertiary is compensatory.
• C. Secondary occurs only in children; tertiary occurs in adults.
• D. Secondary presents with suppressed PTH; tertiary presents with elevated PTH.

Answer: (A)

The main idea is how PTH elevation in CKD-related hyperparathyroidism evolves from a compensatory response to an autonomous secretory state. In chronic kidney disease, phosphate retention and reduced production of active vitamin D lower calcium levels. The parathyroid glands respond by increasing PTH to raise calcium and improve phosphate balance—that’s secondary hyperparathyroidism: a compensatory rise driven by hypocalcemia and vitamin D deficiency. With ongoing stimulation, the glands hyperplasia and can become autonomous, continuing to secrete PTH even when calcium levels are corrected, which defines tertiary hyperparathyroidism. This autonomous secretion is why tertiary hyperparathyroidism can persist or worsen despite treatment addressing the initial hypocalcemia. So the correct distinction is that secondary is a compensatory PTH rise due to CKD-related hypocalcemia/VD deficiency, while tertiary is autonomous PTH secretion after prolonged stimulation.